GlassScriptPhysician profile
Brandon Govan
NPI 1104449677
$1,946.68
in general payments reported to CMS, 2019-2025
15 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $144 · 2023: $619 · 2024: $761 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,433 · Education: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,432.93 |
| Education | $369.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $798.58 | 2023-2025 | Opsumit, Uptravi |
| Glaxosmithkline, LLC. | $501.47 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Baxter Healthcare | $156.64 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| United Therapeutics Corporation | $124.50 | 2023-2024 | Tyvaso |
| Amgen INC. | $99.20 | 2024-2025 | Tavneos |
| Axsome Therapeutics, INC. | $63.69 | 2023-2024 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $38.49 | 2024 | |
| Insmed, INC. | $29.64 | 2025 | Brinsupri, Arikayce |
| Jazz Pharmaceuticals INC. | $25.48 | 2024 | |
| Edwards Lifesciences Corporation | $22.76 | 2022 | |
| Verona Pharma, INC. | $18.36 | 2025 | Ohtuvayre |
| Mylan Specialty L.P. | $18.09 | 2023 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.66 | 2023 | Ofev |
| Genzyme Corporation | $16.75 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $15.37 | 2024 | Fasenra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Govan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.